Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-17

Clinical Trial Update: Omega 3 Fatty Acids and Systemic Lupus Erythematosus [NA]

View source ↗

Summary

This clinical trial update indicates that a study of omega-3 fatty acids for systemic lupus erythematosus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Systemic Lupus Erythematosus | NA | Status: COMPLETED